4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-050282
VP, Clinical Trial Operations sold 6,000 shares at $27.96 ($167,786)
- VP, Clinical Trial Operations acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-20 | Exercise or conversion : show line 1 in the form | +6,000 | $6.00 | $36,000 | 112,135 | D |
| 2023-09-20 | Sale : show line 2 in the form | −6,000 | $27.96 | $167,786 | 106,135 | D |
| Open-market sales · 6,000 sh · avg $27.96 · $167,786 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −6,000 | $6.00 | 2029-09-20 | 6,000 | 223,253 | D |
Loading xslF345X05/doc4.xml…